Asha HIV Health Promotion Intervention in India
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00860769 |
Recruitment Status
:
Completed
First Posted
: March 12, 2009
Last Update Posted
: September 28, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
HIV Infections | Behavioral: ASHA LIFE Behavioral: USUAL Care | Phase 1 Phase 2 |
This Community health study was conducted in two phases:
Phase I was initiated with the establishment of a Community Advisory Board (CAB) composed of 10 persons including WLA, Ashas, and health care providers consisting of Nurse Midwives, HIV and TB experts selected from a Primary Care Clinic in Nellore, Andhra Pradesh. The CAB considered issues related to stigma, disclosure, and psycho-socio-cultural factors affecting the health-seeking behaviors of WLA. They also analyzed the strategies that Asha could employ to support WLA in optimizing their health and well-being and that of their families. This was followed by focus groups conducted separately with the same type of participants. Eligibility criteria included WLA who were currently on ART, were 16-45 years of age, and were able to provide informed consent.
Phase II: A randomized control trial-pilot study was completed in Year 3. We assessed the outcomes of 34 WLA who participated in the AL program at six-month follow-up, as compared with 34 WLA in the Usual Care (UC) Program; in terms of: a) compliance with HIV/AIDS and/or TB treatment regimens (HIV/AIDS/TB), b) improvement in knowledge about HIV/AIDS/TB, c) improvement in psychological distress, d) reduction in stigma, e) reduction in number of opportunistic infections (OIs), f) increase in CD4 levels, and g) completion of the program. The intervention incorporated a comprehensive education and skills program to which we added high protein supplements (1 kg of Black Gram and 1 kg of Toor Dal/month for the AL group vs. a basic program including 1 kg of Channa Dal/month for the UC group.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 68 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | ASHA HIV Health Promotion Intervention in India |
Study Start Date : | September 2008 |
Actual Primary Completion Date : | March 2011 |
Actual Study Completion Date : | June 2012 |

Arm | Intervention/treatment |
---|---|
Experimental: ASHA Life
6-session educational group discussing HIV prevention, anti-retroviral therapy (ART), coping enhancement, nutrition, parenting and life skills.
|
Behavioral: ASHA LIFE
6-session education groups discussing HIV prevention, anti-retroviral therapy (ART), coping enhancement, nutrition, parenting and life skills
|
Active Comparator: Usual Care
3-session educational group focusing on HIV prevention, anti-retroviral therapy (ART) and parenting.
|
Behavioral: USUAL Care
3 session educational group focusing on HIV prevention, anti-retroviral therapy and parenting
|
- Conduct a randomized clinical pilot study with 70 women living with HIV in India. [ Time Frame: 2 years ]
- Acceptability of the intervention by the women living with HIV. [ Time Frame: 2 years ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 45 Years (Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Women living with HIV
- Ages 18-45
- Interfacing with an Accredited Social Health Activist (ASHA)
- Receiving ART or eligible for receiving ART
- HIV Positive status
- CD4 cells ≥ 100
- Not a participant of Phase 1
Exclusion Criteria:
- Cognitively impaired, not a participant of Phase 1

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00860769
India | |
Indian Counsel of Medical Research | |
New Delhi, India |
Principal Investigator: | Adeline Nyamathi, PhD | The Regents of the University of California |
Publications of Results:
Responsible Party: | Adeline Nyamathi, PhD, Distinguished Professor, University of California, Los Angeles |
ClinicalTrials.gov Identifier: | NCT00860769 History of Changes |
Other Study ID Numbers: |
G071208102 1 R34 MH082662:01R |
First Posted: | March 12, 2009 Key Record Dates |
Last Update Posted: | September 28, 2016 |
Last Verified: | September 2016 |
Additional relevant MeSH terms:
HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases |